SEELAS Life Sciences Group Inc - Warrants (18/09/2018)

(GALEW)

By |

Profile

SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S and NeuVax.

Contact Information

Website: www.sellaslifesciences.com
Email: ir@rxipharma.com
Main Phone: +1 917 438-4353
Address: 315 Madison Avenue
Address 2: 4th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10017

Issuer Information

Exchange: OTO
CEO: Angelos Stergiou
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 0.025 $ 0. (0.00%)
Last Price 0.025 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.025
Last Trade Volume 0 52 Wk Hi 0.10 52 Wk Low 0.01
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange OTCPK

News